A detailed history of Morse Asset Management, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Morse Asset Management, Inc holds 7,888 shares of ABBV stock, worth $1.29 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
7,888
Previous 7,890 0.03%
Holding current value
$1.29 Million
Previous $1.22 Million 17.42%
% of portfolio
0.37%
Previous 0.36%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $319 - $364
-2 Reduced 0.03%
7,888 $1.44 Million
Q4 2023

Feb 15, 2024

SELL
$137.6 - $154.97 $138,976 - $156,519
-1,010 Reduced 11.35%
7,890 $1.22 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $1.84 Million - $2.14 Million
-13,806 Reduced 60.8%
8,900 $1.33 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $4.55 Million - $5.66 Million
-34,353 Reduced 60.21%
22,706 $3.06 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $185,100 - $213,171
-1,280 Reduced 2.19%
57,059 $9.09 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $60,441 - $72,485
-437 Reduced 0.74%
58,339 $9.43 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $32,210 - $36,943
-240 Reduced 0.41%
58,776 $7.89 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $301,387 - $383,162
2,190 Added 3.85%
59,016 $9.04 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $346,447 - $429,843
-2,625 Reduced 4.42%
56,826 $9.21 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $67,143 - $84,956
625 Added 1.06%
59,451 $8.05 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $263,127 - $298,688
-2,473 Reduced 4.03%
58,826 $6.35 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $133,616 - $148,856
-1,270 Reduced 2.03%
61,299 $6.91 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $520,195 - $572,672
5,085 Added 8.85%
62,569 $6.77 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $534,856 - $722,112
6,645 Added 13.07%
57,484 $6.16 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $36,082 - $42,348
-420 Reduced 0.82%
50,839 $4.45 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $620,269 - $830,013
8,454 Added 19.75%
51,259 $5.03 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $258,000 - $391,160
4,000 Added 10.31%
42,805 $3.26 Million
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $1.95 Million - $2.44 Million
27,055 Added 230.26%
38,805 $3.44 Million
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $13,140 - $16,796
-200 Reduced 1.67%
11,750 $854,000
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $1.2 Million - $1.41 Million
-15,535 Reduced 56.52%
11,950 $963,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $208,637 - $257,306
-2,680 Reduced 8.88%
27,485 $2.53 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $1.76 Million - $1.96 Million
-19,795 Reduced 39.62%
30,165 $2.85 Million
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $1.19 Million - $1.4 Million
-13,200 Reduced 20.9%
49,960 $4.63 Million
Q1 2018

May 02, 2018

BUY
$92.01 - $123.21 $56,586 - $75,774
615 Added 0.98%
63,160 $5.98 Million
Q4 2017

Jan 29, 2018

BUY
$89.56 - $98.21 $92,694 - $101,647
1,035 Added 1.68%
62,545 $6.05 Million
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $4.3 Million - $5.49 Million
61,510
61,510 $5.47 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Morse Asset Management, Inc Portfolio

Follow Morse Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morse Asset Management, Inc with notifications on news.